At the heart of Eli Lilly's purpose lies a deep understanding: their insulin is more than just a product—it’s essential for peoples’ health and survival.

This purpose, to unite caring with discovery to create medicines that make life better for people around the world, is embedded deeply within the organization. The company focuses on ensuring their medicines are inclusive to all patients by investing in clinical testing diversity and removing obstacles that might prevent patients from accessing their medicine—both at and beyond the pharmacy counter. And, to ensure patients have reliable access to life-saving medications for years to come, Eli Lilly has invested $100 million towards achieving climate goals by 2030. Through this commitment, Eli Lilly is not only safeguarding the planet but reaffirming the company’s dedication to the well-being of every individual who relies on their medicines.

We invited Jim Greffet, Head of ESG Strategy at Eli Lilly, to explain how the company’s environmental and social commitments are grounded in purpose strategy, as well as how the company helps its employees lead purposeful careers.